Inventor · disambiguated record
Gerd Munzert
Also filed as: MUNZERT GERD · MUNZERT GERD MICHAEL
5 granted patents·12 pending applications·25 citations·filing 2004–2025
74Inventor score
Files withBOEHRINGER INGELHEIM INT8MUNZERT GERD3TAUBE TILLMANN3AMGEN RES MUNICH GMBH2STEFANIC MARTIN FRIEDRICH1
Top patents by PatentIndex Score
17 records- 0187US8143247B2Combinations for the treatment of diseases involving cell proliferationMUNZERT GERD·Filed 2009·Granted Mar 27, 2012·13 cites·11 claims
- 0284US8058270B2Dihydropteridinones for the treatment of cancer diseasesMUNZERT GERD·Filed 2008·Granted Nov 15, 2011·11 cites·5 claims
- 0368US8591895B2Combinations for the treatment of diseases involving cell proliferationMUNZERT GERD·Filed 2012·Granted Nov 26, 2013·1 cites·18 claims
- 0462US2014057898A1Combinations for the treatment of diseases involving cell proliferation, migration or apoptosis of myeloma cells, or angiogenesisSTEFANIC MARTIN FRIEDRICH·Filed 2013·Application pending·0 cites
- 0558US2005043233A1Combinations for the treatment of diseases involving cell proliferation, migration or apoptosis of myeloma cells or angiogenesisBOEHRINGER INGELHEIM INT·Filed 2004·Application pending·0 cites
- 0657US2021284732A1Dosing regimen for bcma-cd3 bispecific antibodiesAMGEN RES MUNICH GMBH·Filed 2019·Application pending·0 cites
- 0756US2015265610A1Combinations for the treatment of diseases involving cell proliferation, migration or apoptosis of myeloma cells, or angiogenesisBOEHRINGER INGELHEIM INT·Filed 2015·Application pending·0 cites
- 0856US2011171289A1Combinations for the treatment of diseases involving cell proliferation, migration or apoptosis of myeloma cells, or angiogenesisBOEHRINGER INGELHEIM INT·Filed 2010·Application pending·0 cites
- 0953US2006058311A1Combinations for the treatment of diseases involving cell proliferationBOEHRINGER INGELHEIM INT·Filed 2005·Application pending·0 cites
- 1053US2025154255A1DOSING REGIMEN FOR BCMAx-CD3 ANTIBODIES CONSTRUCTSAMGEN RES MUNICH GMBH·Filed 2025·Application pending·0 cites
- 1153US2019290652A1Method for treatment of solid malignancies including advanced or metastatic solid malignanciesBOEHRINGER INGELHEIM INT·Filed 2019·Application pending·0 cites
- 1250US9358233B2Method for treating acute myeloid leukemiaTAUBE TILLMANN·Filed 2011·Granted Jun 7, 2016·0 cites·9 claims
- 1348US2006074088A1Dihydropteridinones for the treatment of cancer diseasesBOEHRINGER INGELHEIM INT·Filed 2005·Application pending·0 cites
- 1445US2016303131A1Method for treatment of solid malignancies including advanced or metastatic solid malignanciesBOEHRINGER INGELHEIM INT·Filed 2016·Application pending·0 cites
- 1542US2013131069A1Method for treatment of solid malignancies including advanced or metastatic solid malignanciesTAUBE TILLMANN·Filed 2012·Application pending·0 cites
- 1639US2016243124A1Method for treating acute myeloid leukemiaBOEHRINGER INGELHEIM INT·Filed 2016·Application pending·0 cites
- 1732US9370535B2Method for treatment of advanced solid tumorsTAUBE TILLMANN·Filed 2012·Granted Jun 21, 2016·0 cites·8 claims
Join the waitlist — get patent alerts
Get an alert when Gerd Munzert files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →